Strengthening the immunization supply chain: A time-to-supply based approach to cold chain network optimization &amp; extension in Madhya Pradesh

Srivastava, Varun; Ratna, Manish; Ray, Arindam; Shukla, Satya Prakash; Shrivastava, Vipin; Kothari, Nitin; Gupta, Amandeep; Kukreja, Meenal; Jandu, Harkabir Singh

doi:10.1016/j.vaccine.2021.09.062

Cited by 10 publications

(8 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Section: Discussionmentioning

confidence: 99%

“…Similarly, logistic risk consisting of the absence of cold chain availability, counterfeit drugs, lack of personnel and traffic congestion, can be alleviated by network optimization (Huang and Fei, 2019), a robust and sophisticated cold chain with increased capacity (Mohsin and Yellampalli, 2018;Srivastava et al, 2021) and real-time location visibility (Mohsin and Yellampalli, 2018). This risk can also be mitigated with better tracking, traceability and transparency (Musamih et al, 2021), which can be achieved using the latest technologies like blockchain, IoT, machine learning, etc (Ahmadi et al, 2020;Singh et al, 2020;Trenfield et al, 2019).…”

Section: Mitigation Strategiesmentioning

confidence: 99%

See 1 more Smart Citation

Supply chain risk factor assessment of Indian pharmaceutical industry for performance improvement

Sharma

Kumar

Arora

2022

IJPPM

View full text Add to dashboard Cite

PurposeThe purpose of the present work is to improve the industry performance by identifying and quantifying the risks faced by the Indian pharmaceutical industry (IPI). The risk values for the prominent risks and overall industry are determined based on the four risk parameters, which would help determine the most contributive risks for mitigation.Design/methodology/approachAn extensive literature survey was done to identify the risks, which were also validated by industry experts. The finalized risks were then evaluated using the fuzzy synthetic evaluation (FSE) method, which is the most suitable approach for the risk assessment with parameters having a set of different risk levels.FindingsThe three most contributive sub-risks are counterfeit drugs, demand fluctuations and loss of customers due to partners' poor service performance, while the main risks obtained are demand, financial and logistics. Also, the overall risk value indicates that the industry faces medium to high risk.Practical implicationsThe study identifies the critical risks which need to be mitigated for an efficient industry. The industry is most vulnerable to the demand risk category. Therefore, the managers should minimize this risk by mitigating its sub-risks, like demand fluctuations, bullwhip effect, etc. Another critical sub-risk, the counterfeit risk, should be managed by adopting advanced technologies like blockchain, artificial intelligence, etc.Originality/valueThere is insufficient literature focusing on risk quantification. Therefore, this work addresses this gap and obtains the industry's most critical risks. It also discusses suitable mitigation strategies for better industry performance.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Mitigation Strategiesmentioning

confidence: 99%

Supply chain risk factor assessment of Indian pharmaceutical industry for performance improvement

Sharma

Kumar

Arora

2022

IJPPM

View full text Add to dashboard Cite

show abstract

“…Finally, Srivastava et al ( 89 ) used a greedy adding algorithm-based optimization with healthcare facility-level geolocation data to straighten the immunization supply chain in eight districts of Madhya Pradesh, India.…”

Section: Literature Review: Pharmacy-based Immunizationmentioning

confidence: 99%

Pharmacy-based immunization: a systematic review

Romero-Mancilla

Mora-Vargas

Ruíz

2023

Front. Public Health

View full text Add to dashboard Cite

BackgroundThe coronavirus disease 2019 pandemic has prompted the exploration of new response strategies for such health contingencies in the near future. Over the last 15 years, several pharmacy-based immunization (PBI) strategies have emerged seeking to exploit the potential of pharmacies as immunization, medication sale, and rapid test centers. However, the participation of pharmacies during the last pandemic was very uneven from one country to another, suggesting a lack of consensus on the definition of their roles and gaps between the literature and practice.PurposeThis study aimed to consolidate the current state of the literature on PBI, document its progress over time, and identify the gaps not yet addressed. Moreover, this study seeks to (i) provide new researchers with an overview of the studies on PBI and (ii) to inform both public health and private organization managers on the range of possible immunization models and strategies.MethodologyA systematic review of scientific qualitative and quantitative studies on the most important scientific databases was conducted. The Preferred Reporting Items for Systematic Reviews and Meta-analyzes guidelines were followed. Finally, this study discusses the trends, challenges, and limitations on the existing literature on PBI.FindingsMust studies concluded that PBI is a beneficial strategy for the population, particularly in terms of accessibility and territorial equity. However, the effectiveness of PBI is affected by the economic, political, and/or social context of the region. The collaboration between the public (government and health departments) and private (various pharmacy chains) sectors contributes to PBI's success.OriginalityUnlike previous literature reviews on PBI that compiled qualitative and statistical studies, this study reviewed studies proposing mathematical optimization methods to approach PBI.

show abstract

“…The analysis found that the limited number of vaccine manufacturing companies and lack of coordination are to most critical challenges for COVID-19 vaccine distribution. The location of cold storage and inventory allocation decisions at different VSC nodes help reduce the lead time, cost and wastages (Rastegar et al, 2021;Srivastava et al, 2021). For a SVSC, energy, materials and processes used in immunization systems should have as little influence on the environment as possible (Lloyd et al, 2015;Zaffran et al, 2013).…”

Section: Literature Review 21 Vaccine Supply Chain (Vsc)mentioning

confidence: 99%

“…The location of cold storage and inventory allocation decisions at different VSC nodes help reduce the lead time, cost and wastages (Rastegar et al. , 2021; Srivastava et al. , 2021).…”

Section: Literature Reviewmentioning

confidence: 99%

A fuzzy decision framework of lean-agile-green (LAG) practices for sustainable vaccine supply chain

Yadav

Kumar

2022

IJPPM

View full text Add to dashboard Cite

PurposeThe already-strained vaccine supply chain (VSC) of the expanded program for immunization (EPI) require a more robust and structured distribution network for pandemic/outbreak vaccination due to huge volume demand and time constraint. In this paper, a lean-agile-green (LAG) practices approach is proposed to improve the operational, economic and environmental efficiency of the VSC.Design/methodology/approachA fuzzy decision framework of importance performance analysis (IPA)–analytical hierarchy process (AHP)–technique for order for preference by similarity in ideal solution (TOPSIS) has been presented in this paper to prioritize the LAG practices on the basis of the influence on performance indicators. Sensitivity analysis is carried out to check the robustness of the presented model.FindingsThe derived result indicates that sustainable packaging, coordination among supply chain stakeholders and cold chain technology improvement are among the top practices affecting most of the performance parameters of VSC. The sensitivity analysis reveals that the priority of practices is highly dependent on the weightage of performance indicators.Practical implicationsThis study's finding will help policymakers reframe strategies for sustainable VSC (SVSC) by including new management practices that can handle regular immunization programs as well as emergency mass vaccination.Originality/valueTo the best of the authors' knowledge, this is the first study that proposes the LAG framework for SVSC. The IPA–Fuzzy AHP (FAHP)–Fuzyy TOPSIS (FTOPSIS) is also a novel combination in decision-making.

show abstract

Strengthening the immunization supply chain: A time-to-supply based approach to cold chain network optimization & extension in Madhya Pradesh

Cited by 10 publications

References 30 publications

Supply chain risk factor assessment of Indian pharmaceutical industry for performance improvement

Supply chain risk factor assessment of Indian pharmaceutical industry for performance improvement

Pharmacy-based immunization: a systematic review

A fuzzy decision framework of lean-agile-green (LAG) practices for sustainable vaccine supply chain

Contact Info

Product

Resources

About